- SFG FRC 2027 | Program starts from 19th Dec. 2026 | Admissions open for Entrance Test Click Here to know more →
- Prelims Test Series (PTS) for Prelims 2027 starts 11th Oct. 2026 Click Here to know more →
- [Pre-order] Ethics Redbook 3rd Edition: Delivery starts from 10th October onwards Click Here to Read More →
- 21 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 11th Oct. Click Here to Read More →
Source: This post is based on the article “New antibiotic identified to target a drug-resistant bacterium” published in “The Hindu” on 4 January 2024.
Why in news?
Researchers have identified a new class of antibiotics called ‘Zosurabalpin’ with the potential to tackle a drug-resistant bacterium, Acinetobacter baumannii.
What is Zosurabalpin?
1) Zosurabalpin is an antibody that is effective against CRAB (carbapenem-resistant Acinetobacter baumannii)-induced pneumonia and sepsis in mouse models.
2) Scientists identified a tethered macrocyclic peptide (MCP) that selectively kills A. baumannii which was further optimised for efficacy and tolerability, resulting in zosurabalpin.
3) The antibiotic kills A. baumannii through a previously unknown mode of action. It inhibits the transport of the molecule lipopolysaccharide (LPS) by inhibiting a complex of proteins.
4) This complex was essential for transporting LPS to the bacterial surface to create the outer-membrane structure of Gram-negative bacteria. However, the blocking of the LPS transport results in an abnormal build-up of LPS in the cell which kills the bacterium.
5) The antibiotic demonstrated efficacy against over 100 clinically tested samples of CRAB in the laboratory.
UPSC Syllabus- Science & Technology
